Experience

ETAP-Lab - Preclinical CRO

• France
• Research Services
• 1 - 100 Employee

• Preclinical Project Manager in Neuroscience

  • Jan 2019 - Present

  Development of new preclinical models of human pathologies in rodents across the fields of neuroscience, neurodegenerative diseases and cerebral aging. Management of in vivo preclinical efficacy studies for external sponsors. Development of new preclinical models of human pathologies in rodents across the fields of neuroscience, neurodegenerative diseases and cerebral aging. Management of in vivo preclinical efficacy studies for external sponsors.



SEGILAB LVD55

• R&D and Quality Assurance Manager

  • Sep 2017 - Jul 2018

  Design of R&D projects to develop ultrasensitive molecular biology techniques to detect pathogens in cattle. Analyses of changes in technology and regulations, mastery of standards and test methods, management of non-conformities, planning and control of equipment calibrations. Design of R&D projects to develop ultrasensitive molecular biology techniques to detect pathogens in cattle. Analyses of changes in technology and regulations, mastery of standards and test methods, management of non-conformities, planning and control of equipment calibrations.



Fondation de Coopération Scientifique de Besançon

• Project Manager in Biochemistry

  • Mar 2016 - Mar 2017

  Management of characterization and formulation studies on lipoproteins for therapeutic evaluation in inflammatory diseases in mice. Management of characterization and formulation studies on lipoproteins for therapeutic evaluation in inflammatory diseases in mice.



Universite de Lorraine

• France
• Higher Education
• 700 & Above Employee

• Temporary teaching and research assistant at Université de Lorraine

  • Sep 2014 - Aug 2015

  Lectures, tutorials and practical works in the fields of Biochemistry and Biology during my doctoral studies.

• PHD Student

  • Nov 2011 - Jun 2015

  Management of in vivo studies on functional consequences of brain membrane aging and protection by dietary n-3 polyunsaturated fatty acids (PUFAs). Testing of the beneficial/detrimental effects of different dietary (PUFAs, high-fat) on brain aging, learning and memory and on the biological response of therapeutic targets in Alzheimer’s disease.